Literature DB >> 9922979

Antimurine retroviral effect of doxycycline.

F G Sturtz1.   

Abstract

The tetracycline family is composed of several molecules whose antibacterial properties are due to the fixation on the bacterial ribosomes. Among those, doxycycline is one of the most potent antibiotics for which additional features have been recently discovered. Doxycycline has been found to inhibit metalloproteinases, to decrease gelatinolytic and metastatic activities of cancer cells, to have a "chondroprotective" effect in inflammatory arthritides, and to have strong antimalarial properties. In this study, a murine retrovirus producing cell line (psi CRIP-pXT1) was incubated in variable concentrations of doxycycline. The retroviral titer of this cell line was measured by the ability to transfer resistance to G418 to NIH/3T3 cells. The retroviral titer was significantly decreased by 70% when the packaging cells had been incubated with 25 microM of doxycycline at 37 degrees C. The ID50 was around 8 micrograms/ml. Astonishingly, this effect was not observed at 32 degrees C. The mechanism of this effect is still to be determined. It may be useful to be aware of this effect for uncovering all of the possible antiviral qualities of doxycycline and its related molecules, such as glycylcyclines or anthracyclines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9922979     DOI: 10.1358/mf.1998.20.8.487489

Source DB:  PubMed          Journal:  Methods Find Exp Clin Pharmacol        ISSN: 0379-0355


  9 in total

Review 1.  Pharmacological basis for the potential role of Azithromycin and Doxycycline in management of COVID-19.

Authors:  Ahmed S Ali; Mai A ASattar; Shahid Karim; Dina Kutbi; Hanin Aljohani; Duaa Bakhshwin; Mohammed Alsieni; Huda M Alkreathy
Journal:  Arab J Chem       Date:  2021-01-10       Impact factor: 5.165

Review 2.  Repurposing of antibiotics for clinical management of COVID-19: a narrative review.

Authors:  Abdourahamane Yacouba; Ahmed Olowo-Okere; Ismaeel Yunusa
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-05-21       Impact factor: 3.944

3.  A combination of doxycycline and ribavirin alleviated chikungunya infection.

Authors:  Hussin A Rothan; Hirbod Bahrani; Zulqarnain Mohamed; Teow Chong Teoh; Esaki M Shankar; Noorsaadah A Rahman; Rohana Yusof
Journal:  PLoS One       Date:  2015-05-13       Impact factor: 3.240

4.  Doxycycline: From Ocular Rosacea to COVID-19 Anosmia. New Insight Into the Coronavirus Outbreak.

Authors:  Chiara Bonzano; Davide Borroni; Andrea Lancia; Elisabetta Bonzano
Journal:  Front Med (Lausanne)       Date:  2020-05-08

5.  In Vitro Effects of Doxycycline on Replication of Feline Coronavirus.

Authors:  Magdalena Dunowska; Sayani Ghosh
Journal:  Pathogens       Date:  2021-03-07

Review 6.  Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery.

Authors:  Leena Abdulaziz; Esraa Elhadi; Ejlal A Abdallah; Fadlalbaseer A Alnoor; Bashir A Yousef
Journal:  J Exp Pharmacol       Date:  2022-03-08

7.  Novel approach by natural language processing for COVID-19 knowledge discovery.

Authors:  Li Wang; Lei Jiang; Dongyan Pan; Qinghua Wang; Zeyu Yin; Zijian Kang; Haoran Tian; Xuqiang Geng; Jinsong Shao; Wenjie Pan; Jian Yin; Li Fang; Yue Wang; Weide Zhang; Zhixiu Li; Jun Zheng; Wenxin Hu; Yunbao Pan; Dong Yu; Shicheng Guo; Wei Lu; Qiang Li; Yunyun Zhou; Huji Xu
Journal:  Biomed J       Date:  2022-04-01       Impact factor: 7.892

8.  Therapeutic Potential for Tetracyclines in the Treatment of COVID-19.

Authors:  Mohit Sodhi; Mahyar Etminan
Journal:  Pharmacotherapy       Date:  2020-05-04       Impact factor: 4.705

9.  Computational insights into tetracyclines as inhibitors against SARS-CoV-2 Mpro via combinatorial molecular simulation calculations.

Authors:  Shiv Bharadwaj; Kyung Eun Lee; Vivek Dhar Dwivedi; Sang Gu Kang
Journal:  Life Sci       Date:  2020-07-09       Impact factor: 6.780

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.